Stock PSNL PERSONALIS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Personalis, Inc.

Equities

PSNL

US71535D1063

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
1.57 USD -4.85% Intraday chart for Personalis, Inc. +1.95% -25.24%
May. 08 Transcript : Personalis, Inc., Q1 2024 Earnings Call, May 08, 2024
May. 08 Earnings Flash (PSNL) PERSONALIS Reports Q1 Revenue $19.5M, vs. Street Est of $18.4M MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Personalis: Q1 Earnings Snapshot
AQ
Personalis Reports First Quarter 2024 Financial Results
BU
Personalis to Announce First Quarter 2024 Financial Results
BU
Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference
BU
Data Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting
BU
Personalis Announces Publication Validating NeXT Personal Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring
AQ
Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring
BU
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
Personalis: Q4 Earnings Snapshot
AQ
Personalis Reports Fourth Quarter and Full Year 2023 Financial Results
BU
Personalis to Announce Fourth Quarter and Full Year 2023 Financial Results
BU
Personalis to Participate at Upcoming Investor Conferences
BU
Personalis and ClearNote Health Announce Partnership to Advance Epigenomic Technology
BU
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
Personalis Announces Medicare Coverage for NeXT Dx Comprehensive Genomic Tumor Profiling Assay
AQ
Personalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling Assay
BU
Personalis Reports Preliminary Fourth Quarter and Full Year 2023 Revenue and Cash Balance
BU
Personalis Extends Cash Position Into 2026, Provides Update on Key Initiatives
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PSNL Stock
  4. News Personalis, Inc.
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW